418 related articles for article (PubMed ID: 23707581)
21. Simultaneous multi-region detection of GABA+ and Glx using 3D spatially resolved SLOW-editing and EPSI-readout at 7T.
Weng G; Slotboom J; Schucht P; Ermiş E; Wiest R; Klöppel S; Peter J; Zubak I; Radojewski P
Neuroimage; 2024 Feb; 286():120511. PubMed ID: 38184158
[TBL] [Abstract][Full Text] [Related]
22. Individual differences in GABA content are reliable but are not uniform across the human cortex.
Greenhouse I; Noah S; Maddock RJ; Ivry RB
Neuroimage; 2016 Oct; 139():1-7. PubMed ID: 27288552
[No Abstract] [Full Text] [Related]
23. Brain glutathione and GABA+ levels in autistic children.
Song Y; Hupfeld KE; Davies-Jenkins CW; Zöllner HJ; Murali-Manohar S; Mumuni AN; Crocetti D; Yedavalli V; Oeltzschner G; Alessi N; Batschelett MA; Puts NAJ; Mostofsky SH; Edden RAE
Autism Res; 2024 Mar; 17(3):512-528. PubMed ID: 38279628
[TBL] [Abstract][Full Text] [Related]
24. High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI Instrument.
Taki MM; Harada M; Mori K; Kubo H; Nose A; Matsuda T; Nishitani H
Neuroimage; 2009 Oct; 47(4):1207-14. PubMed ID: 19481612
[TBL] [Abstract][Full Text] [Related]
25. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
[TBL] [Abstract][Full Text] [Related]
26. Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment.
Huang D; Liu D; Yin J; Qian T; Shrestha S; Ni H
Eur Radiol; 2017 Jul; 27(7):2698-2705. PubMed ID: 27966041
[TBL] [Abstract][Full Text] [Related]
27. Spectral-editing measurements of GABA in the human brain with and without macromolecule suppression.
Harris AD; Puts NA; Barker PB; Edden RA
Magn Reson Med; 2015 Dec; 74(6):1523-9. PubMed ID: 25521836
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal assessment of
Ferland MC; Therrien-Blanchet JM; Lefebvre G; Klees-Themens G; Proulx S; Théoret H
Exp Brain Res; 2019 Dec; 237(12):3461-3474. PubMed ID: 31734787
[TBL] [Abstract][Full Text] [Related]
29. Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.
Horder J; Lavender T; Mendez MA; O'Gorman R; Daly E; Craig MC; Lythgoe DJ; Barker GJ; Murphy DG
Transl Psychiatry; 2013 Jul; 3(7):e279. PubMed ID: 23838890
[TBL] [Abstract][Full Text] [Related]
30. Biochemistry of the cingulate cortex in autism: An MR spectroscopy study.
Libero LE; Reid MA; White DM; Salibi N; Lahti AC; Kana RK
Autism Res; 2016 Jun; 9(6):643-57. PubMed ID: 26526126
[TBL] [Abstract][Full Text] [Related]
31. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder.
Pretzsch CM; Freyberg J; Voinescu B; Lythgoe D; Horder J; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Edden RAE; Williams S; Murphy DGM; Daly E; McAlonan GM
Neuropsychopharmacology; 2019 Jul; 44(8):1398-1405. PubMed ID: 30758329
[TBL] [Abstract][Full Text] [Related]
32. A Multimodal Study of the Contributions of Conduction Velocity to the Auditory Evoked Neuromagnetic Response: Anomalies in Autism Spectrum Disorder.
Roberts TPL; Bloy L; Ku M; Blaskey L; Jackel CR; Edgar JC; Berman JI
Autism Res; 2020 Oct; 13(10):1730-1745. PubMed ID: 32924333
[TBL] [Abstract][Full Text] [Related]
33. Insights from auditory cortex for GABA+ magnetic resonance spectroscopy studies of aging.
Dobri S; Chen JJ; Ross B
Eur J Neurosci; 2022 Aug; 56(4):4425-4444. PubMed ID: 35781900
[TBL] [Abstract][Full Text] [Related]
34. Altered neurotransmitter metabolism in adolescents with high-functioning autism.
Drenthen GS; Barendse EM; Aldenkamp AP; van Veenendaal TM; Puts NA; Edden RA; Zinger S; Thoonen G; Hendriks MP; Kessels RP; Jansen JF
Psychiatry Res Neuroimaging; 2016 Oct; 256():44-49. PubMed ID: 27685800
[TBL] [Abstract][Full Text] [Related]
35. A Proton Magnetic Resonance Spectroscopic Study in Autism Spectrum Disorder Using a 3-Tesla Clinical Magnetic Resonance Imaging (MRI) System: The Anterior Cingulate Cortex and the Left Cerebellum.
Ito H; Mori K; Harada M; Hisaoka S; Toda Y; Mori T; Goji A; Abe Y; Miyazaki M; Kagami S
J Child Neurol; 2017 Jul; 32(8):731-739. PubMed ID: 28420309
[TBL] [Abstract][Full Text] [Related]
36. Measurement of variation in the human cerebral GABA level by in vivo MEGA-editing proton MR spectroscopy using a clinical 3 T instrument and its dependence on brain region and the female menstrual cycle.
Harada M; Kubo H; Nose A; Nishitani H; Matsuda T
Hum Brain Mapp; 2011 May; 32(5):828-33. PubMed ID: 20645307
[TBL] [Abstract][Full Text] [Related]
37. Absence of changes in GABA concentrations with age and gender in the human anterior cingulate cortex: a MEGA-PRESS study with symmetric editing pulse frequencies for macromolecule suppression.
Aufhaus E; Weber-Fahr W; Sack M; Tunc-Skarka N; Oberthuer G; Hoerst M; Meyer-Lindenberg A; Boettcher U; Ende G
Magn Reson Med; 2013 Feb; 69(2):317-20. PubMed ID: 22488982
[TBL] [Abstract][Full Text] [Related]
38. Regional difference in GABA levels between medial prefrontal and occipital cortices.
van der Veen JW; Shen J
J Magn Reson Imaging; 2013 Sep; 38(3):745-50. PubMed ID: 23349060
[TBL] [Abstract][Full Text] [Related]
39. In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese.
Dydak U; Jiang YM; Long LL; Zhu H; Chen J; Li WM; Edden RA; Hu S; Fu X; Long Z; Mo XA; Meier D; Harezlak J; Aschner M; Murdoch JB; Zheng W
Environ Health Perspect; 2011 Feb; 119(2):219-24. PubMed ID: 20876035
[TBL] [Abstract][Full Text] [Related]
40. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
